文献速递糖尿病

激活性SKAP2突变与糖尿病合并多自身免疫及炎症状况相关

Diabetes With Multiple Autoimmune and Inflammatory Conditions Linked to an Activating SKAP2 Mutation.
PubMed 文献 · Diabetes Care · 2021-06-25

该研究在一名24岁1型糖尿病合并其他自身免疫及炎症状况的患者中鉴定出新生SKAP2变异(c.457G>A,p.Gly153Arg)。功能实验显示该变异位于保守脂质结合环,导致整合素通路活性增强及无趋化因子刺激下的迁移表型,为功能获得性致病突变,可能破坏髓系免疫细胞功能并打破免疫耐受。

要点

  • 在1型糖尿病合并多自身免疫及炎症状况患者中鉴定出新生SKAP2 p.Gly153Arg变异。
  • 该变异为功能获得性致病突变,导致髓系免疫细胞整合素通路活性增强和自发迁移。
  • 提示激活性SKAP2变异可能通过破坏免疫耐受参与自身免疫性1型糖尿病。

核心结论

  • SKAP2在髓系细胞活化和迁移中起关键作用。
  • 该患者中的激活性SKAP2变异提示其参与自身免疫性1型糖尿病。

研究设计与样本

  • 病例报告结合全外显子测序,研究对象为一名24岁1型糖尿病合并其他自身免疫及炎症状况的患者及其一级亲属。
  • 功能研究使用细胞系及从家庭成员采集的原代髓系免疫细胞。

主要发现

  • 测序发现先证者携带新生SKAP2变异c.457G>A(p.Gly153Arg)。
  • 患者单核细胞来源巨噬细胞显示整合素通路活性增强及无趋化因子刺激下的迁移表型。
  • p.Gly153Arg变异位于高度保守的脂质结合环,在人巨噬细胞系中表达诱导相似表型。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: Multiple genome-wide association studies have identified a strong genetic linkage between the SKAP2 locus and type 1 diabetes (T1D), but how this leads to disease remains obscure. Here, we characterized the functional consequence of a novel SKAP2 coding mutation in a patient with T1D to gain further insight into how this impacts immune tolerance. RESEARCH DESIGN AND METHODS: We identified a 24-year-old individual with T1D and other autoimmune and inflammatory conditions. The proband and first-degree relatives were recruited for whole-exome sequencing. Functional studies of the protein variant were performed using a cell line and primary myeloid immune cells collected from family members. RESULTS: Sequencing identified a de novo SKAP2 variant (c.457G>A, p.Gly153Arg) in the proband. Assays using monocyte-derived macrophages from the individual revealed enhanced activity of integrin pathways and a migratory phenotype in the absence of chemokine stimulation, consistent with SKAP2 p.Gly153Arg being constitutively active. The p.Gly153Arg variant, located in the well-conserved lipid-binding loop, induced similar phenotypes when expressed in a human macrophage cell line. SKAP2 p.Gly153Arg is a gain-of-function, pathogenic mutation that disrupts myeloid immune cell function, likely resulting in a break in immune tolerance and T1D. CONCLUSIONS: SKAP2 plays a key role in myeloid cell activation and migration. This particular mutation in a patient with T1D and multiple autoimmune conditions implicates a role for activating SKAP2 variants in autoimmune T1D.

来源:Diabetes Care,查看原文。版权归原作者所有。

引用

  1. Rutsch N, Chamberlain CE, Dixon W, et al. Diabetes With Multiple Autoimmune and Inflammatory Conditions Linked to an Activating SKAP2 Mutation. Diabetes Care. 2021. PMID: 34172489. doi:10.2337/dc20-2317

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。